As an example, multi-drug resistance in AML was reported to correlate with low levels of EZH2 expression due to Cyclin Dependent Kinase 1 (CDK1) and Heat Shock Protein 90 (HSP90) mediated proteasomal degradation. This evidence concerns the gene EZH2 and acute myeloid leukemia.